Yahoo · Sep 17, 2026
Altria Just Sued the FDA. Here’s What It Means for Your Dividend Check
Key TakeawaysPost-Earnings Reversal: Altria’s Q2 adjusted EPS of $1. 48 missed consensus by two cents and sent shares down as much as 9% to $68, their worst single day since June 2022, even as management raised the low end of full-year guidance to $5.


